Need more? Try out  Advanced Search (20+ criteria)»


Last Update

This profile was last updated on 6/19/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong JoAnn Pinkerton?

JoAnn V. Pinkerton

Executive Director

North American Menopause Society

HQ Phone:  (440) 442-7550

Email: p***@***.org


+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.


  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

North American Menopause Society

5900 Landerbrook Drive Suite 390

Cleveland, Ohio,44124

United States

Company Description

Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging....more

Background Information

Employment History

Professor of Obstetrics and Gynecology

University of Virginia

Executive Director


Medical Director

Midlife Dimensions



Board Member

National Women's Health Resource Center Inc

Vice Chair of the Board of Directors

Healthy Women

Board Member

OBG Management

Board Member


W4mtp Council Member


Member of the Board of Editors of OBG Management

American College of Obstetricians and Gynecologists


American Medical Women's Association


Virginia Obstetrics and Gynecology Society


Board of Trustees

past-President of Professional Education Committee



Vascular Institute , New Orleans


University of Virginia

Medical Doctor degree

Medical College of Virginia

undergraduate degree

University of Virginia

Web References(185 Total References)

While stretching before bed isn't a bad idea, Dr. JoAnn Pinkerton, executive director of The North American Menopause Society, told Reuters Health by email, "it is impossible to tell if the positive effect found from stretching on menopausal and depressive symptoms was due to the stretching, the increased movement, or not doing whatever they normally do during the 10 minutes before bed such as eat, smoke or drink, etc."
Pinkerton said the results would have been more interesting if the comparison group had been assigned a task to do before bedtime, to see if it was the stretching itself that was helpful or just the fact of doing something before bed. In most studies of methods for reducing hot flashes, the placebo group sees some improvement, too, she pointed out. In this trial, the comparison group had no improvement at all, which means, she said, that it was not an adequate control group. For more conclusive results, Pinkerton said, "this study needs to be replicated with larger, more diverse postmenopausal women with an active control group." In the meantime, she added, women should remember that "being sedentary has been shown to be bad for (their) physical and mental health and to increase hot flashes. Being active every day has been shown to lessen severity of hot flashes, improve mood, coping ability and may decrease (their) risk of cognitive loss." Additionally, Pinkerton said, "if women were to exercise with light walking 30 minutes daily and then stretch for 10 minutes, they might improve health, menopausal symptoms, mood and cognition and, if stretching helps sleep, improve their sleep quality." [cached]

JoAnn PinkertonChair Dr. JoAnn V. Pinkerton is Medical Director of Midlife Health Center and Professor of Obstetrics and Gynecology at the University of Virginia, Charlottesville.Her clinical research focus includes sexual dysfunction, hormone replacement, selective estrogen receptor modulators, and osteoporosis prevention and treatment options.Dr. Pinkerton is a long-term member of the North American Menopause Society (NAMS), serves on its Board of Trustees, and is past-President of its professional education committee.Dr. Pinkerton is a Fellow of the American College of Obstetricians and Gynecologists and a member of the Virginia Obstetrics and Gynecology Society and the American Medical Women's Association.She is also involved in Web-based education for NAMS, The Endocrine Society, and the National Organization for Women's Health. [cached]

JoAnn V. Pinkerton, MD
Professor, Department of Obstetrics and Gynecology, Division of Midlife Health, University of Virginia Health Center, Charlottesville, Virginia; Executive Director, North American Menopause Society, Mayfield Heights, Ohio [cached]

"This study demonstrates that there is an unmet need for postmenopausal women to have regular gynecologic visits where questions can be asked about vaginal and urinary health problems and assessment can be made to determine the presence of vulvovaginal atrophy, urinary symptoms of urgency or incontinence or pelvic floor disorders and offer FDA approved safe and effective therapies," says NAMS Executive Director JoAnn V. Pinkerton, MD, NCMP "Women need to tell their healthcare providers about their genitourinary symptoms, and providers need to ask."
The boxed warnings on the low-dose intra vaginal estrogen therapies for GSM (also known as vulvovaginal atrophy or VVA) may have made providers reluctant to prescribe them and women to use them. "The boxed warnings prompt a level of fear that is out of step with these low-dose, local estrogen products," said Dr. Pinkerton. That prompted experts from NAMS and leaders from other scientific organizations to go to FDA recently to request removing this warning from the label information. The NAMS experts who spoke to FDA stressed that providers should exercise caution and evaluate the uterus if women develop bleeding as well as advising women to discuss the use of low-dose intra vaginal estrogen with their oncologist if they have had cancer. "Diagnosis of these problems requires a pelvic exam and evaluation of the vaginal and vulva tissues to look for atrophy, prolapse, or infection, noted Dr. Pinkerton. [cached]

As NAMS Executive Director JoAnn V. Pinkerton, MD, NCMP, points out, "Many women with incontinence find themselves limiting physical activity out of fears of leakage.
But women with bone loss or at risk for bone loss need strength training in addition to adequate calcium and vitamin D to prevent further bone loss and decrease fracture risk." Dr. Pinkerton finds this study particularly important for clinical care of these women because of the sustained, long-term improvement in incontinence with physical therapy in the group of postmenopausal women who need treatment the most; those who already have bone loss and need physical activity to improve their bone density.

Similar Profiles


Browse ZoomInfo's Business
Contact Directory by City


Browse ZoomInfo's
Business People Directory


Browse ZoomInfo's
Advanced Company Directory